Clinical Trial Update: Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on combining capecitabine (Xeloda) with paclitaxel for gastric cancer with liver metastasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Xeloda (capecitabine)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN